UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 5
May-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2505216


Registration ID:
561482

Page Number

c153-c163

Share This Article


Jetir RMS

Title

Superiority of haemocoagulase over other haemostats in bleeding management: A survey of medical practitioners

Abstract

In 2024, India recorded over 30 million surgical procedures, with a significant majority, approximately 85%, performed in small to mid-sized hospitals, and only 15% conducted in corporate healthcare institutions. Bleeding remains a common and critical complication during surgeries, posing ongoing challenges for surgeons. According to the World Health Organization (WHO), intraoperative bleeding occurs in about 15% of all surgical cases and in up to 50% of cardiac surgeries. Postoperative bleeding affects up to 20% of patients, often resulting in extended hospital stays, increased treatment costs, and elevated risks of morbidity and mortality. These statistics underscore the urgent need for effective haemostatic agents that can control bleeding both during and after surgical procedures. Haemocoagulase has demonstrated superior haemostatic efficacy by significantly reducing perioperative bleeding without impairing the patient's coagulation function. It has established itself as a dependable component of clinical treatment protocols. This research undertakes a comprehensive review of scientific literature and a survey of physician perspectives to assess and validate the superiority of haemocoagulase as a haemostat. The convergence of findings from clinical studies, physician insights, and market analysis affirms haemocoagulase’s effectiveness, safety profile, and strong potential for market expansion. Overall, this study concludes that haemocoagulase stands out as a superior haemostatic agent compared to other available options.

Key Words

Haemocoagulase, Surgical bleeding management, haemostats, Batroxobin, Thrombin, clotting

Cite This Article

"Superiority of haemocoagulase over other haemostats in bleeding management: A survey of medical practitioners", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 5, page no.c153-c163, May-2025, Available :http://www.jetir.org/papers/JETIR2505216.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Superiority of haemocoagulase over other haemostats in bleeding management: A survey of medical practitioners", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 5, page no. ppc153-c163, May-2025, Available at : http://www.jetir.org/papers/JETIR2505216.pdf

Publication Details

Published Paper ID: JETIR2505216
Registration ID: 561482
Published In: Volume 12 | Issue 5 | Year May-2025
DOI (Digital Object Identifier): https://doi.org/10.56975/jetir.v12i5.561482
Page No: c153-c163
Country: SHIVAMOGGA, Karnataka, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000139

Print This Page

Current Call For Paper

Jetir RMS